Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
Policy and Medicine Compliance Update October 2023 Issue Features: Complex…
We begin our coverage in Policy and Medicine Compliance Update this month by examining the complex world of medical education. The…
Kentucky Files Lawsuit Against PBMs, Drug Manufacturers Over Insulin Prices
Recently, the Commonwealth of Kentucky filed a lawsuit against pharmacy benefit managers (PBMs) and drug manufacturers over the…
CMS Clarifies Direct Negotiation Guidelines
The Biden administration has released new guidance for its program that will allow Medicare to directly negotiate the prices of…
Merck Sues to Stop Drug Price Negotiation Program
Recently, Merck & Co sued the United States Department of Health and Human Services (HHS) and Centers for Medicare and…
MedPAC to Forward Three Recommendations to Congress to Target Prescription…
During the April 2023 Medicare Payment Advisory Commission (MedPAC) meeting, the Commission unanimously approved three…
Industry Pushing Back on Medicare Drug Price Negotiations
Reuters recently reported that some of the largest pharmaceutical companies are planning to fight the United States plan to…
PhRMA Releases Report on Global Prescription Drug Access
The Pharmaceutical Research and Manufacturers of America (PhRMA) recently published a new report that analyzes the share of new…
CMS Outlines Medicare Drug Price Negotiation Program for 2026
On March 15, 2023, CMS released initial guidance detailing the requirements and parameters on key elements of the new Medicare…
Ohio Attorney General Sues Express Scripts and Others for Driving Up Drug…
Ohio Attorney General David Yost filed a lawsuit against Ascent Health Services, Express Scripts Inc., Cigna Group, Evernorth…
CMS Publishes Initial Guidance Documents For Inflation Rebate Provisions
On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) published two “initial” guidance documents (Part B and…